Advanced Method for Predicting Response to Midostaurin plus Chemotherapy in Acute Myeloid Leukaemia Greatly Outperforms Current Companion Diagnostic
Kinomica Ltd., a developer of diagnostics for precision oncology, today announces significant findings have been published in eBioMedicine demonstrating its phosphoproteomic stratification method outperforms FLT3 mutational status in predicting midostaurin combined with intensive chemotherapy (MIC) response in acute myeloid leukaemia (AML). https://mma.prnewswire.com/media/2422786/Kinomica_Logo.jpg The paper may be accessed viahttps://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00352-9/fulltext The publication details how mass spectrometry phosphoproteomics […]